Leonard Frank X 4

What Happened Leonard Frank X, CEO of NovoCure Ltd (NVCR), disposed of 34,273 shares on June 4, 2026 in a sale that generated approximately $614,635 in gross proceeds. The reported weighted-average sale price was $17.93 per share (trade prices ranged $17.665–$18.37). This was a sell-to-cover transaction to satisfy tax withholding obligations related to vested Restricted Stock Units, not a discretionary open‑market sell for investment purposes.

Key Details

• Transaction date: 2026-06-04; Form 4 filed: 2026-06-05 (timely).
• Shares sold: 34,273; weighted-average price: $17.93; gross proceeds: ~$614,635.
• Price range across multiple trades: $17.665 to $18.37 (see footnote F2).
• Reason: Mandatory sell-to-cover for tax withholding on RSU vesting under the company’s award agreement (footnote F1).
• Shares owned after transaction: Not specified in the provided filing.
• Transaction code: S (Sale); footnote F1 indicates tax-withholding requirement (code F conceptually).

Context Sell-to-cover transactions are common when restricted stock units vest and generally reflect tax obligation mechanics rather than a manager expressing a view on the stock. Because this sale was mandated by the award agreement to satisfy withholding, it should be interpreted as routine administrative activity rather than a discretionary insider divestment.